Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
All > Germany >

Deals > Northern Germany

Find below deals from the Northern German Federal States of Bremen (HB), Hamburg (HH), Mecklenburg-Vorpommern (MVP), Niedersachsen (NS) and Schleswig-Holstein (SWH). Listed are deals for this region as well as from organisations located there.

Total search results: 299 | Ordered by Date (descending)
1 2 3  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Stimit–Dräger: investment, 202104 acquisition of majority share in Stimit AG by Drägerwerk AG & Co KGaA 2021-04-01
Indivumed–Live Wire Strategic Communications: public relations, 202103 service existent by Live Wire 2021-03-18
Avacta–Bruker: MS-based SARS-CoV-2 test, 202101– collab developm of BAMS SARS-CoV-2 assay on Bruker MALDI-TOF as IVD test 2021-01-28
GeneQuine–Brandenburg (govt): grant, 202101 grant €900k from investment bank of federal state Brandenburg 2021-01-26
GeneQuine–High-Tech Gründerfonds: investment, 202101 financing round Series A totalling €5.4m incl existing + co-investor HTGF 2021-01-26
GeneQuine–Noshaq: investment, 202101 financing round Series A totalling €5.4m incl co-investor Noshaq SA 2021-01-26
GeneQuine–Pacira BioSciences: credit, 202101 convertible loans totalling €2.75m from Pacira + Samum Vermögensverwaltungs GmbH 2021-01-26
GeneQuine–Pacira BioSciences: investment, 202101 financing round Series A totalling €5.4m incl lead investor Pacira BioSciences 2021-01-26
GeneQuine–Samum: credit, 202101 convertible loans totalling €2.75m from Pacira BioSciences Inc + Samum Vermögensverwaltungs GmbH 2021-01-26
GeneQuine–Samum: investment, 202101 financing round Series A totalling €5.4m incl co-investor Samum Vermögensverwaltungs GmbH 2021-01-26
GeneQuine–SEVERAL: investment, 202101 financing round Series A €5.4m led by Pacira BioSciences 2021-01-26
LignoPure–Hamburg (govt): investment, 202101 seed financing round totalling €2.2m incl investor Innovationsstarter Fonds Hamburg GmbH 2021-01-18
LignoPure–High-Tech Gründerfonds: investment, 202101 seed financing round totalling €2.2m incl investor HTGF 2021-01-18
LignoPure–SEVERAL: investment, 202101 seed financing round €2.2m from HTGF + IFH + Tanovis AG 2021-01-18
LignoPure–Tanovis: investment, 202101 seed financing round totalling €2.2m incl investor Tanovis AG 2021-01-18
AmpTec–Merck (DE): investment, 202101 acquisition €na of AmpTec GmbH bei Merck 2021-01-07
Curexsys–Evotec: investment, 202012 seed financing round totalling €8.2m incl Evotec acquiring 37% equity stake 2020-12-09
Curexsys–Sartorius: investment, 202012 seed financing round totalling €8.2m incl Sartorius acquiring 21% equity stake 2020-12-09
Curexsys–SEVERAL: investment, 202012 seed financing round €8.2m led by Evotec + Sartorius 2020-12-09
Topas Therapeutics–BioMedPartners: investment, 202010 financing round Series B totalling €22m incl new + co-lead investor BioMedPartners 2020-10-19
Topas Therapeutics–Boehringer: investment, 202010 financing round Series B totalling €22m incl existing + co-investor BIVF 2020-10-19
Topas Therapeutics–EMBL: investment, 202010 financing round Series B totalling €22m incl existing + co-investor EMBL Ventures 2020-10-19
Topas Therapeutics–Epidarex Capital: investment, 202010 financing round Series B totalling €22m incl existing + co-investor Epidarex Capital 2020-10-19
Topas Therapeutics–Evotec: investment, 202010 financing round Series B totalling €22m incl existing + co-investor Evotec 2020-10-19
Topas Therapeutics–Gimv: investment, 202010 financing round Series B totalling €22m incl existing + co-investor Gimv 2020-10-19
Topas Therapeutics–SEVERAL: investment, 202010 financing round Series B €22m co-led by Vesalius + BioMedPartners plus all existing investors 2020-10-19
Topas Therapeutics–Vesalius Biocapital: investment, 202010 financing round Series B totalling €22m incl new + co-lead investor Vesalius Biocapital III 2020-10-19
Iksuda Therapeutics–Univ Göttingen: antibody-drug conjugates, 202010– license excl ww to new class of prodrug payloads for ADCs using PermaLink 2020-10-13
Evotec–Univ Oxford: biobanking, 202009– collab €na granting Evotec access to QUOD biobank for multi-omics analyses for drug discovery 2020-09-02
Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab 2020-08-07
Quantro Therapeutics–Evotec: drug discovery services, 202007– supply of hit identification services by Evotec 2020-07-21
Quantro Therapeutics–Evotec: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
KI-SIGS project–Germany (govt): grant, 202005– funding €10m from German federal government 2020-05-27
Exscientia–Evotec: investment, 202005 financing round Series C totalling $60m incl existing + co-investor Evotec 2020-05-26
Enzymicals–Syngulon: enzyme production technology, 202005– license non-excl to antibiotic-free selection technology of Syngulon 2020-05-16
OTHER–Enzymicals: enzymes, 202005 service production + supply of diagnostic enzymes using antibiotic-free production for undisclosed world leader 2020-05-16
Centogene–Ubirch: blockchain technology, 202004 collab announcing secure blockchain solution for storing SARS-CoV-2 test results 2020-04-17
Evotec–Leon-Nanodrugs: nanoparticle technology, 202004– collab €na strategic partnership incl equity investment 2020-04-16
Leon-Nanodrugs–Evotec: investment, 202004 financing round Series B incl new + lead investor Evotec 2020-04-16
Centogene–FTI Consulting: public relations, 202004 service existent by FTI Consulting 2020-04-15
Evotec–PanCella: iPSC technology, 202004– license €na for use of iACT Stealth Cells + FailSafe technology with EVOcells platform 2020-04-02
PanCella–Evotec: investment, 202004 minority equity investment €na by Evotec in connection with license agreement 2020-04-02
Provirex–Hamburg (govt): investment, 202003 seed financing from Ascenion + Innovationsstarter Fonds Hamburg 2020-03-31
Provirex–Helmholtz: investment, 202003 seed financing from Ascenion + Innovationsstarter Fonds Hamburg 2020-03-31
Koki Holdings–Eppendorf: investment, 202003– acquisition €na of Koki’s Centrifuge + Processing business by Eppendorf from KKR 2020-03-19
Merck (DE)–Dermapharm: investment, 202002–202003 acquisition €na of Merck’s allergy business Allergopharma by Dermapharm Holding SE 2020-02-19
Temedica–Public Performance: public relations, 202002 service existent by Public Performance 2020-02-01
Bayer–Evotec: drug discovery services, 201001–202412 collab expansion women’s health €16.5m upfront + research cost + milestones >€330m drugs for PCOS 2020-01-09
Riemser–Esteve: investment, 202001– acquisition €na of Riemser from Ardian by Esteve 2020-01-08
Bruker–Adeptrix: MS-based immunoassays, 202101– collab developm BAMS assays on Bruker MALDI-MS systems 2020-01-06
Aeovian Pharmaceuticals–Evotec: investment, 201912 investment existent Evotec owns 5.83% of voting rights 2019-12-31
Autobahn Labs–Evotec: investment, 201912 investment existent Evotec owns 33.33% of voting rights 2019-12-31
Blacksmith Medicines–Evotec: investment, 201912 investment existent Evotec owns 15.09% of voting rights 2019-12-31
Breakpoint Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 48.6% of voting rights 2019-12-31
Carrick Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 4.29% of voting rights 2019-12-31
Celmatix–Evotec: investment, 201912 investment existent Evotec owns 25.02% of voting rights 2019-12-31
Eternygen–Evotec: investment, 201912 investment existent Evotec owns 24.97% of voting rights 2019-12-31
Exscientia–Evotec: investment, 201912 investment existent Evotec owns 23.21% of voting rights 2019-12-31
Fibrocor Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 16% of voting rights of Fibrocor LLP 2019-12-31
Forge Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 15.09% of voting rights 2019-12-31
FSHD Unlimited Coop–Evotec: investment, 201912 investment existent Evotec owns 21.12% of voting rights 2019-12-31
Immunitas Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 6.44% of voting rights 2019-12-31
Topas Therapeutics–Evotec: investment, 201912 investment existent Evotec owns 28.44% of voting rights 2019-12-31
Provecs–NONE: investment, 201912–202001 bankruptcy AG Hamburg 67g IN 290/19 insolvency + dissolution Provecs Medical GmbH 2019-12-30
Abcalis–Germany (govt): grant, 201912 EXIST research transfer grant for founding from BMWi (plus ESF grant) 2019-12-10
Biological Industries (IL)–Sartorius: investment, 201912 acquisition of just over 50% for €45m in cash with option to acquire further 20% 2019-12-05
Indivumed–Biognosys: MS-based proteomics, 201912– collab integration of HRM MS proteomics data into multi-omics IndivuType cancer database 2019-12-02
Immunitas Therapeutics–Evotec: investment, 201911 financing round Series A totalling $39m incl co-investor Evotec 2019-11-21
Evotec–Merck (DE): CRISPR technology, 201911– license to CRISPR IP portfolio from Merck to Evotec 2019-11-12
Vifor Pharma–Evotec: drug r+d, 201911– collab establishment 50/50 joint venture for nephrology treatments using NURTuRE biobank + PanHunter s/w 2019-11-06
AstraZeneca–BBG/Braun Group: quetiapine fumarate, 201910– acquisition $178m upfront + up to $61m rights to Seroquel/XR in Europe + RU by Cheplapharm 2019-10-30
Danaher–Sartorius: investment, 201910– acquisition $750m three life science businesses by Sartorius part of regulatory clearance for GE/Danaher deal 2019-10-21
Celmatix–Evotec: drug discovery services, 201910– collab €na developm pre-clinical programs for reproductive women’s health 2019-10-09
Dalhousie Univ–Thermo Fisher: mass spectrometer, 201910 supply C$1.3m of Orbitrap Fusion MS system to MS + Proteomics Core Faclity 2019-10-07
Aeovian Pharmaceuticals–Apollo Ventures: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Apollo Health Ventures 2019-10-03
Aeovian Pharmaceuticals–Evotec: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Evotec 2019-10-03
Takeda–Evotec: drug discovery services, 201909– collab strategic multi-year across multiple indications 2019-09-24
LemnaTec–Nynomic: investment, 201908 acquisition €na of assets of bankrupt LemnaTec Gmbh by Nynomic AG 2019-08-12
Ncardia–Evotec: investment, 201907 acquisition €na of iPSC assets + 17 strong team of bankrupt Ncardia AG in Cologne 2019-07-15
Breakpoint Therapeutics–Evotec: investment, 201907 first financing round totalling €30m incl co-investor Evotec 2019-07-08
Breakpoint Therapeutics–Medicxi Ventures: investment, 201907 first financing round totalling €30m incl lead investor Medicxi 2019-07-08
Breakpoint Therapeutics–Otsuka: investment, 201907 first financing round totalling €30m incl co-investor Taiho Ventures LLC 2019-07-08
Breakpoint Therapeutics–SEVERAL: investment, 201907 first financing round €30m for spin-out from Evotec led by Medicxi + incl Taiho Ventures + Evotec 2019-07-08
Nosopharm–Evotec: antibiotics, 201907– collab €na pre-clinical developm of NOSO-502 + 2nd generation odilorhabdin 2019-07-03
Evotec–SEVERAL: credit, 201906– promissory note €250m with lead arrangers Deutsche Bank + LBBW 2019-06-26
Osteolabs–MVZ Dr Krause: investment, 201906 seed financing round incl investor MVZ Dr Krause und Kollegen Kiel 2019-06-17
Osteolabs–OTHER: investment, 201906 seed financing round incl two business angel investors 2019-06-17
Osteolabs–Schleswig-Holstein (govt): investment, 201906 seed financing round incl investor MGB Kiel Seed und Start-Up Fonds II 2019-06-17
Osteolabs–SEVERAL: investment, 201906 seed financing round from MGB Kiel + MVZ Dr Krause Kiel + two business angels 2019-06-17
Evotec–Leucadia: investor conference, 201906 supply service Evotec AG presents at Jefferies 2019 Global Healthcare Conference NYC 2019-06-06
Evotec–Deutsche Bank: investor conference, 201906 supply service Evotec presents at dbAccess Berlin Conference 2019-06-05
Bruker–908 Devices: sample separation technology, 201906– collab integration of ZipChip microfluidics separation with Bruker TOF systems 2019-06-03
Bruker–Genedata: bioinformatics, 201905– collab product integration Genedata Expressionist supports timsTOF MS systems data 2019-05-31
Bruker–PreOmics: sample preparation technology, 201905– collab developm + marketing PreOmics iST sample preparation on timsTOF Pro MS system 2019-05-31
Helmholtz–Bruker: mass spectrometry software, 201905 supply existent HIPS long-time user of SCiLS Lab + MetaboScape s/w 2019-05-31
Medical Univ South Carolina–Bruker: mass spectrometer, 201905 supply existent timsTOF fleX system early customer Proteomics Center at Med Univ SC 2019-05-31
PHW-Gruppe–Ampersand: investment, 201905 acquisition of Vibalogics GmbH by Ampersand Capital Partners 2019-05-29
Evotec–RBC Capital Markets: investor conference, 201905 supply service Evotec presents at RBC Capital Markets Global Healthcare Conference 2019-05-22
Evotec–Berenberg: investor conference, 201905 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2019-05-21
Just Biotherapeutics (US)–Evotec: investment, 201905–201907 acquisition 100% for $60m upfront + $30m upfront 2019-05-20
1 2 3  next pagenext page



Advertisement

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px

» top